Patient
SITE009-0070
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2025-11-26
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-02-16 (study day 260); relationship: not assessed
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-14 (study day 258); relationship: not assessed
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-01-30 (study day 243); relationship: NOT RELATED
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-09-21 (study day 112); relationship: not assessed
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-09-16 (study day 107); relationship: not assessed
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-08-29 (study day 89); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.